About Eurekam
Eurekam is a company based in Lagord (France) founded in 2012 by Loic Tamarelle and Benoit Le Franc.. Eurekam has raised $8.84 million across 3 funding rounds from investors including Bpifrance, Impact Partners and Sofimac Investment Managers. Eurekam offers products and services including Drugcam Oncology and Drugcam Vaccine. Eurekam operates in a competitive market with competitors including House Rx, DecisionRx, GalenusRx, Prescription Advisory Systems & Technology and Pillcheck, among others.
- Headquarter Lagord, France
- Founders Loic Tamarelle, Benoit Le Franc
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.84 M (USD)
in 3 rounds
-
Latest Funding Round
$6.34 M (USD), Series B
Oct 05, 2022
-
Investors
Bpifrance
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eurekam
Eurekam offers a comprehensive portfolio of products and services, including Drugcam Oncology and Drugcam Vaccine. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Ensures accurate preparation of cancer chemotherapy drugs
Facilitates safe production of vaccine doses
Funding Insights of Eurekam
Eurekam has successfully raised a total of $8.84M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $6.34 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $6.3M
-
First Round
First Round
(16 Jul 2013)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Series B - Eurekam | Valuation |
investors |
|
| Apr, 2018 | Amount | Series A - Eurekam | Valuation |
investors |
|
| Jul, 2013 | Amount | Seed - Eurekam | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Eurekam
Eurekam has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Bpifrance, Impact Partners and Sofimac Investment Managers. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Early to Growth stage VC & PE firm funding
|
Founded Year | Domain | Location | |
|
Private equity firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Eurekam
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Eurekam
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Eurekam Comparisons
Competitors of Eurekam
Eurekam operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as House Rx, DecisionRx, GalenusRx, Prescription Advisory Systems & Technology and Pillcheck, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Technology-based medication solutions are provided for patients and caregivers.
|
|
| domain | founded_year | HQ Location |
Medication management solutions are provided to patients and healthcare providers.
|
|
| domain | founded_year | HQ Location |
Medication safety risk management solutions are provided for healthcare organizations.
|
|
| domain | founded_year | HQ Location |
Software for Doctors to Help Treat Pain & Reduce Abuse of Controlled Substances
|
|
| domain | founded_year | HQ Location |
DNA testing platform for user medication responses is offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Eurekam
When was Eurekam founded?
Eurekam was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Eurekam located?
Eurekam is headquartered in Lagord, France. It is registered at Lagord, Charente-maritime, France.
Is Eurekam a funded company?
Eurekam is a funded company, having raised a total of $8.84M across 3 funding rounds to date. The company's 1st funding round was a Seed of $653.23K, raised on Jul 16, 2013.
What does Eurekam do?
Eurekam was founded in 2012 in Lagord, France, as a provider of medication management solutions in the oncology sector. An AI-based platform called DRUGCAM is offered, which uses video to prevent errors in chemotherapy treatments through monitoring of active substances, administration methods, and dosages for real-time validation. Additional tools support documentation of drug preparations and therapy management for clinical optimization.
Who are the top competitors of Eurekam?
Eurekam's top competitors include House Rx, DecisionRx and GalenusRx.
What products or services does Eurekam offer?
Eurekam offers Drugcam Oncology and Drugcam Vaccine.
Who are Eurekam's investors?
Eurekam has 6 investors. Key investors include Bpifrance, Impact Partners, Sofimac Investment Managers, Aquiti Gestion, and FIP - International Pharmaceutical Federation.